It has been recognised recently that obese individuals have lower concentrations of micronutrients and this may affect the concentrations of inflammatory cytokines. A cross-sectional study was carried out to evaluate the association of specific micronutrients' status with chronic inflammation caused by obesity in 280 women (36·1 (SD 7·5) years) from seven rural communities in Mexico. Measurements of weight, height and waist circumference were made on all women and body composition was determined by dual-energy X-ray absorptiometry. Concentrations of the cytokines IL-1, TNF-a, IL-6, IL-10 and IL-12, lipid profile, and the micronutrients Zn and vitamins A, C and E were determined in fasting blood samples. Ordered logistic regression models were used to determine associations between categorised cytokine levels and micronutrients. It was found that 80 % of women were overweight or obese, and had significantly higher concentrations of C-reactive protein than normal-weight women (P¼ 0·05). The risk of higher levels of TNF-a, IL-6, IL-10 and IL-12 was reduced significantly among women with higher Zn concentrations (OR 0·63, 95 % CI 0·42, 0·96, P¼ 0·03; OR 0·57, 95 % CI 0·39, 0·86, P¼ 0·025; OR 0·63, 95 % CI 0·41, 0·96, P¼ 0·04; OR 0·62, 95 % CI 0·41, 0·95, P¼0·03, respectively). Higher concentrations of vitamin A were slightly associated with reduced risks of higher levels of IL-1 and IL-12 (OR 0·97, 95 % CI 0·95, 0·99, P¼0·03; OR 0·97, 95 % CI 0·94, 0·99, P¼0·03, respectively); when adjusting for BMI, this association was lost. No associations were found between vitamin C or vitamin E:lipids concentrations and inflammatory cytokines. In conclusion, higher Zn concentrations are associated with reduced risks of higher concentration of inflammation markers in a population of women with a high prevalence of obesity.
The growing burden of obesity-associated chronic diseases is now one of the more important health issues in the world. Obesity and excess abdominal fat are risk factors for a broad range of chronic diseases such as hypertension, CVD and type 2 diabetes mellitus, all of which are now the principal causes of mortality worldwide (1 -3) . The burden of this complex of diseases is now becoming an acute problem in industrialising countries passing through an epidemiological and nutrition transition. Mexico, for example, is one of the countries with the highest prevalence of obesity, as found in a 2006 National Nutrition Survey of Mexico (Encuesta Nacional de Salud y Nutrición; ENSANUT 2006), and this prevalence is increasing year after year (4) .
Obesity has been described as a form of low-grade inflammation (5) . Inflammatory cytokines such as TNF-a, IL-1 and IL-6, which are important risk factors for chronic diseases, are elevated in obese individuals. These cytokines are principally produced through signalling pathways located within the adipocytes that make up the white adipose tissue. Their circulating concentrations directly correlate with adipocyte size and number (6) . Leptin, an adipokine that promotes the sensation of satiety, plays an important role in promoting the expression of such inflammatory cytokines (7) . Also, leptin is involved in the activation and infiltration of macrophages into white adipose tissue (6) , the activation of natural killer cells (8) , and suppresses the proliferation of CD4 þ and CD25 þ Treg cells (9) , and also regulates the T-helper (Th) 1 and Th2 response (10) . Micronutrient status is associated with obesity and may have an important effect on the inflammatory response (11) . Studies have shown that low Zn serum concentration is associated with an increased risk of being obese (11) . Zn may regulate the inflammatory response by up-regulating leptin synthesis, by directly activating monocytes, or through its role in Zn-a2-glycoprotein (ZAG) which is involved in TNF-a transcription (12, 13) . A vitamin A-deficient diet in animal models is associated with increased leptin expression in white adipose tissue and brown adipose tissue (14, 15) . Vitamin A and its active metabolites inhibit the inflammatory Th1 response and promote the Th2 response (16) . Vitamin E has also been found to function as an anti-inflammatory agent in studies concerned with inflammation and pulmonary function in asthma patients as well as inflammation in rats with induced asthma (17, 18) . Vitamin C has been
shown to have anti-inflammatory effects by reducing C-reactive protein (CRP) serum concentrations (19, 20) . It is still not clear what effect each micronutrient has on these inflammatory response pathways among individuals who differ in adiposity and body mass. Also, studies have shown that the intake of certain foods, such as legumes, whole grains, fruits and vegetables, that have a high content of micronutrients including Zn, and vitamins A, C and E, have been associated with lower markers of inflammation (21 -23) .
The objective of the present study was to examine how micronutrient blood concentrations and measures of adiposity are associated with the inflammatory response among Mexican women with a high prevalence of overweight and obesity. The further clarification of this relationship could lead to the development of new preventive and therapeutic micronutrient interventions that contribute to the reduction in the burden of obesity and its complications.
Experimental methods

Study population
The population for this study was 280 women, 25 -55 years of age, who resided in six rural communities located within the Mexican State of Querétaro. Women were excluded from the study if they had uncontrolled diabetes, if they had received treatment for obesity or had taken vitamin and mineral supplements in the previous 3 months. Pregnant and lactating women, as well as women who had any type of eating disorder, were also excluded from the study. The present study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects/patients were approved by the Human Research Committee of the School of Natural Sciences at the Universidad Autónoma de Querétaro (UAQ). Written informed consent was obtained from all subjects/patients.
The sample size of 280 subjects in this study was intended to find a significant OR of 0·50 or 1·75 between two independent groups with different concentrations of cytokines, with an a error of 5 %, b error of 20 %, and an estimated prevalence of a micronutrient deficiency of 20 % (24) .
Study design
This study was cross-sectional in design, in which all enrolled women were first interviewed during an initial household visit to determine clinical histories of chronic disease. Subsequently, these women were then transported at different dates to the Metabolic Unit at the School of Natural Sciences within UAQ, where anthropometric and body composition determinations were made in one session.
A single, basal 5 ml blood sample was drawn from all women who had been fasting for the previous 12 h for the determination of glucose concentrations, lipid profile, Zn, vitamins A, C and E concentrations and concentrations of inflammatory and adaptive immune response cytokines. These samples were collected from the women, at the local health clinic in their respective communities.
Anthropometry and body composition methods
The women wearing light clothing were weighed using a scale (SECA ONDA Mod 843; SECA) with a precision of 1·0 g, while their stature was determined with a precision of 0·1 cm using a portable stadiometer (SECA Mod 206; SECA). Hip circumference was determined with a precision of 0·1 cm using flexible metal tapes (SECA Mod 200; SECA). All measurements were done, non-consecutively, in duplicate by personnel, that had been previously standardised in their application according to procedures developed by Lohman et al. (25) . Women were then categorised as normal weight (BMI ,24·9 kg/m 2 ), overweight (BMI between 25·0 and 29·9 kg/m 2 ) and obese (BMI .30·0 kg/m 2 ), using the WHO classification system (26, 27) . Body composition determinations, percentage of body fat and percentage of abdominal fat, were carried out during this session using DEXA (Hologic, Mod Explorer) in the Metabolic Unit of UAQ, by a certified technician. High body fat was considered with values $ 30 % of total body mass (28) . Abdominal fat was obtained as described previously (29) .
Briefly, abdominal fat is determined from a 10 cm rectangle that is drawn in the X-ray body diagram, immediately above the ileac crest of the subject and it is extended to the sides over the border of the subject's anatomy.
Laboratory methods
Leptin and C-reactive protein determinations. Concentrations of leptin and CRP in plasma were measured in duplicate using commercial ELISA kits (Human Leptin Elisa Kit, Linco Research; High Sensitivity C-Reactive Protein Elisa Kit, Bioquant). Determination of inflammatory and adaptive immune response cytokines. The concentrations of the inflammatoryrelated cytokines, IL-1b, IL-6, IL-8, TNF and IL-12p70, and the anti-inflammatory cytokine IL-10 were measured simultaneously using flow cytometry analysis with the human inflammation kit (Becton Dickinson). Briefly, the serum samples (50 ml) were incubated 1·5 h in the dark with the appropriate dilution of the capture beads, which were then washed by centrifugation and followed by their incubation for an additional 1·5 h. The beads were then washed again by centrifugation and quantified in a FACSCAN (Becton Dickinson) equipped with a 488 nm laser. The data were analysed using the BD CellQuest software, with positive controls provided by the supplier.
Determination of zinc in plasma. Zn concentrations in plasma were measured using flame atomic absorption spectrophotometry (Perkin Elmer, Mod. Analyst 700) using the corresponding certified standards. Zn deficiency was defined as plasma concentrations of , 700 mg/l (30) . Determination of vitamins A, E and C in plasma. Vitamins A and E were simultaneously determined by reversed-phase HPLC (WATERS) using a C18 column (WATERS) with a mobile phase of 100 % methanol (J. T. Baker) and a 1 ml/min flow with a temperature of 408C, measured at a wavelength of 300 nm. Vitamin C was measured by HPLC (WATERS), using a C18 column (WATERS) with a mobile phase of 0·01 M-NaH 2 PO 4 and 0·2 mM-EDTA, a 0·85 ml/min flow, and measured at a wavelength of 254 nm.
Determination of glucose and lipid profile. Fasting glucose concentration was measured by an enzymaticcolorimetric method using the commercial kit Glucose-PAP (Elitech) with a Clinical Analyser Bayer RA-50 (Bayer Diagnostics). Plasma concentration of total cholesterol, HDL and total TAG were measured using commercial kits (Cholesterol SL, Triglycerides, Cholesterol HDL SL 2G, Elitech) in a Bayer RA-50 Analyzer (Bayer Diagnostics). LDL was calculated from the previously mentioned data using the Friedewald method (31) . Biochemical and immunological assays of all samples were carried out in duplicate in the Human Nutrition Laboratory in the School of Natural Sciences at UAQ.
Data analysis
Data were entered in Excel (Microsoft), verified, and checked for range and consistency. Women were considered Zn-deficient if they had plasma concentrations below 700 mg/l (30) , and vitamin A-deficient if they had plasma concentrations , 200 mg/l (32) . Women were classified as vitamin E-deficient if they had concentrations , 5 mg/ml or , 2·4 mmol a-tocopherol:mmol lipid, and finally, vitamin C-deficient if they had plasma concentrations , 2 mg/ml (32, 33) . Women were classified as having high glucose if they had a fasting plasma concentration of glucose above 1260 mg/l (34) . Women were classified with normal lipid concentration if they had cholesterol , 2000 mg/l, TAG , 1500 mg/l and HDL-cholesterol . 350 mg/l (35) . The primary end points for this analysis were the plasma concentrations of pro-and anti-inflammatory cytokines and chemokines among all enrolled women from whom blood samples were taken. Means and standard deviations of physical and biochemical characteristics of enrolled women were first determined to summarise the data.
Associations between measures of obesity, total body fat in kg and percentage, and abdominal fat and plasma concentrations of the pro-inflammatory cytokines IL-1, IL-6, IL-8, IL-12, TNF-a and the anti-inflammatory cytokine IL-10 cytokine were determined as a first step in the overall analysis. Conventional analytical techniques could not be used to analyse these cytokines as endpoints, since an important proportion of samples had no detectable concentration of cytokines. Accordingly, ordered logistic regression analyses were used, which models the probability distributions of cytokine values categorised into three levels ordered from lowest to highest: undetectable, ,median of positives, . median of positives (36) . The inclusion of BMI, abdominal fat (%) and waist-to-height index in the model tested the hypothesis that the probability distributions of categorised cytokine values will differ according to differences in these measures expressed as an OR. Ordinal logistical analyses were then carried out to determine the associations between leptin with the pro-inflammatory and anti-inflammatory cytokines. Leptin analysis was controlled for age and CRP concentrations. These analyses were meant to determine whether leptin is the intermediate mechanism underlying the associations between measures of obesity and body fat and cytokine plasma concentrations.
A final set of analyses was then carried out to test the hypothesis that the probability distributions of categorised cytokine values will vary by differences in the micronutrient plasma concentration again expressed as an OR. As such, analyses were first carried out with the variables for plasma concentrations of vitamin A, vitamin C, vitamin E adjusted for lipids, and Zn included separately in models for each cytokine. Models were then run, which included all the micronutrient variables together in models for each cytokine to control for any interactions between the different micronutrients analysed. Thus, results are presented adjusted for micronutrient concentrations all together, age and CRP concentrations, and further adjusted for BMI. Statistical significance was set at a probability level of , 0·05 and , 0·1 for interactions. Data were analysed using ordered logistics procedure (OLOGIT) in the STATA (version 10) software (STATACorp LP).
Results
A total of 280 women were enrolled in the study. The anthropometric and metabolic characteristics of the women at the beginning of the study are summarised in Table 1 . The prevalence of obesity and overweight was 43·9 and 36·4 %, respectively. In addition, 21·7 % had hypertriacylglycerolaemia, 37·8 % had high total cholesterol and 11·8 % of the women had low levels of HDL. Overall, 4, 15·5 and 16·7 % of women had deficiencies of vitamin C, vitamin E and Zn, respectively, while no women were found to have vitamin A deficiency. When adjusting for total lipids, 11 % of the participants had vitamin E deficiency.
Ordered logistical regression models were first used to analyse the associations between measures of obesity and adiposity with probability of higher cytokine and chemokine levels. Women with higher BMI, a greater percentage of abdominal fat or a greater waist-to-height index were found to have an increased probability of having higher concentrations of IL-6 (OR 1·05, 95 % CI 1·01, 1·09, P¼0·01; OR 1·03, 95 % CI 1·00, 1·07, P¼0·05 and OR 12·89, 95 % CI 0·92, 179·5, P¼0·04, respectively). No significant association was found between increased odds for the other cytokines and other anthropometric measures of obesity (Table 2) . No association was found between leptin and cytokines when included in the models.
The ordered logistical regression models were then used to analyse the associations between serum micronutrient concentrations and the probability of higher cytokine and chemokine concentrations. The OR of having higher concentrations of TNF-a, IL-6, IL-10 and IL-12 were reduced for women with higher concentrations of plasma Zn (OR 0·63, 95 % CI 0·42, 0·96, P¼ 0·03; OR 0·57, 95 % CI 0·39, 0·86, P¼0·025; OR 0·63, 95 % CI 0·41, 0·96, P¼ 0·04 and OR 0·62, 95 % CI 0·41, 0·95, P¼ 0·03, respectively) ( Table 3 ). Higher concentrations of vitamin A were associated with reduced risks of higher levels of IL-1 and IL-12 (OR 0·97, 95 % CI 0·95, 0·99, P¼0·03; OR 0·97, 95 % CI 0·94, 0·99, P¼0·03, respectively). This association disappears when adjusting for BMI. No associations between inflammation markers and vitamin C or vitamin E adjusted for lipids were found.
Discussion
The present study has characterised the relationship between inflammatory cytokine markers and measures of obesity and adiposity among women, and also how serum concentrations of micronutrients are associated with inflammatory cytokine markers. Higher concentrations of plasma Zn were associated with reduced levels of inflammatory cytokines.
The significant association found between IL-6 and measures of obesity and body composition is consistent with other studies which have found that this cytokine is associated with adiposity (37) . Mohamed-Ali et al. (38) , for example, reported that approximately 30 % of in vivo circulating levels of IL-6 was secreted by adipose tissue and that this release was greater in obese subjects. Vozarova et al. (39) also found that fasting plasma IL-6 concentrations were positively related to adiposity but negatively related to insulin action in Pima Indians. In contrast to our findings, TNF-a also has been reported to be significantly elevated in obese, insulin-resistant rodents and humans (40, 41) . However, Kern et al.
, reported that IL-6 levels were much higher in both adipose tissue and plasma in obese subjects while no significant differences in TNF-a secretion by adipose tissue depots was found between obese and lean subjects. These inconsistent observations support the lack of association for this cytokine and adiposity measures found in the present study.
The lack of correlation between leptin levels with any of the inflammation cytokine markers is not consistent with reports from other studies (42) . However, the relationship between leptin and inflammatory cytokines reported in previous studies is not always consistent. For example, an inverse relationship between leptin and IL-6 as well as other inflammation markers was found among rheumatoid arthritis patients (43) . In vitro studies of human and rat monocytes have also found that leptin enhances the expression of proinflammatory cytokines like IL-6, IL-8 and TNF-a (44, 45) . Xiao et al. (46) , in contrast, reported a reduction in IL-6 and TNF-a among primates immunised with endotoxin after treating them with leptin. The lack of an association between leptin and inflammation found in this study may be due to the low grade of inflammation and cytokine concentrations seen in obesity, which may not provide adequate statistical power relative to that reported in acute inflammation states or in cell lines. Overall, these findings suggest that, in this population, leptin may not be directly involved in the pathway that leads to chronic inflammation among obese individuals. The reduced odds of higher levels of the inflammatory markers TNF-a, IL-6 and IL-12 among women with higher Zn concentration is similar to the findings by Bao et al. (47) . They reported that Zn supplementation of elder subjects was associated with decreased concentrations of plasma inflammatory cytokines. Much research has been carried out about Zn concerning the pathways that may be involved in the association of Zn and the immune system; there is still no consensus. However, the strongest theory involves Zn regulation of Zn-dependent enzymes related with the immune system (48) .
One of these enzymes is ZAG, a soluble cytokine that down-regulates the expression of TNF-a. Bao et al. (49) consider ZAG an important beneficial factor for obesity (49) . The expression of ZAG is down-regulated in obese subjects (50) . Thus, Zn may protect against chronic inflammation through the expression of ZAG and its down-regulation effect on TNF-a.
In the present study, the odds of having higher levels of the anti-inflammatory cytokine IL-10 was also reduced with high Zn concentrations. Similarly, it has been observed in both in vitro and human studies that Zn supplementation decreases IL-10 concentrations (51, 52) . In addition, obese individuals have increased pro-inflammatory and anti-inflammatory cytokines (53) . Obese women, for example, before a gastric bypass, had significantly higher IL-10 concentrations compared to normal-weight women (54) . TNF-a, IL-6 and IL-10 concentrations were significantly higher in obese patients with heart failure than in non-obese patients with mild heart failure (55) . This has also been observed in patients during an infectious disease episode, where the concentrations of the anti-inflammatory cytokine IL-10 are increased in response to increased inflammatory cytokine concentrations in order to minimise damage to the host and to avoid tissue damage. This simultaneous response then allows the immune response to return to homeostasis once the infection or the antigen is cleared (56) . Something similar might be occurring in obese or overweight individuals, or with Zn deficiency, where elevated concentrations of IL-10 may be part of a mechanism to counteract the effect of the pro-inflammatory cytokines (53) . The anti-inflammatory effect of IL-10 has been attributed to its ability to inhibit the maturation of antigen-presenting cells, but preserving the capacity of the cells to load the antigens. Also, it has been suggested that it may produce a pro-inflammatory response when antigen-loaded antigenpresenting cells activate local immune responses (57) . Thus, Zn concentrations may play an important role in the pleiotropic effects of IL-10.
Vitamin A is recognised to down-regulate the expression of inflammation markers and promote a Th2 immune response by binding with its membrane receptor retinoic acid receptor-a that inhibits the production of interferon-g, a mediator of other inflammation markers (16, 58) . In this study, higher concentrations of vitamin A are associated with decreased odds of having higher levels of inflammation markers, although this association is only found for the cytokines IL-1 and IL-12 and is not as great as that seen with Zn. When adjusting for obesity, no effect was found between vitamin A concentrations and the levels of inflammation markers. These results may reflect the fact that subjects in this study were not vitamin A-deficient. In vitamin A deficiency, there is an increase of pro-inflammatory cytokines that promotes a Th1-type inflammatory response, while the production of anti-inflammatory cytokines, such as IL-10, is reduced (59, 60) . Table 2 . For example, in Indonesian children, vitamin A deficiency was associated with a higher Th1 response (61) . Similarly, the production of IL-10 was negatively associated with vitamin A stores in adult men (62) . Thus, vitamin A deficiency increases the production of pro-inflammatory cytokines and reduces the concentration of anti-inflammatory cytokines.
Vitamin C and vitamin E:lipids were not associated with any of the cytokines studied. Findings on the relationship between vitamin C and vitamin E with inflammatory markers have been inconsistent (18 -20,63 -66) . For example, intakes of vitamin C and vitamin E were not associated with CRP or IL-6 in 5181 participants from the Multi-Ethnic Study of Atherosclerosis (64) . In contrast, Mah et al. (65) found an inverse relationship between vitamin C status and inflammatory markers among obese men compared with a group of lean adult men in a cross-sectional study, but found no association between vitamin E status and CRP concentrations or inflammatory cytokines. Similarly, Wannamethee et al. (19) reported that vitamin C status was inversely associated with CRP concentrations and lower endothelial dysfunction in men with no history of CVD or diabetes. These epidemiological studies show that vitamin C status is associated with CRP while no associations have been found between vitamin C status and vitamin E status with the inflammatory cytokine response, similar to the findings in the present study.
Supplementation studies have also reported mixed results. Bruunsgaard et al. (66) found no difference in the concentration of IL-6 or TNF-a among adult men supplemented with vitamins C and E for 36 months compared to men who received a placebo. In contrast, Block et al. (20) reported that vitamin C supplementation for 2 months was associated with a 24 % reduction in plasma concentrations of the inflammatory marker CRP. Increases in vitamin E plasma concentrations after supplementing with vitamin E and vitamin C for 2 weeks were associated with lower TNF-a concentrations in adult men with impaired fasting glucose (67) . These inconsistencies regarding the effect of vitamin E on inflammation may be due to the different forms of this vitamin that are found in the diet or given as supplements. Berdnikov et al. (18) , for example, reported that the a-tocopherol and D-a-tocopherol isoforms of vitamin E have opposing immunoregulatory effects on the inflammatory response. The lack of consistency in the clinical trials may also be explained by the differences in the supplementation period that range from 2 weeks to 3 years and/or the doses given. More studies are needed to understand the effect of vitamin C and vitamin E on inflammatory markers.
A number of methodological limitations of our study need to be addressed. The cross-sectional design of the study complicates efforts to determine causality between body composition and obesity, serum micronutrient concentrations and inflammatory cytokines. For example, it is not possible to determine whether elevated inflammatory cytokines may be affecting serum micronutrient concentrations or whether micronutrient concentrations are affecting inflammatory cytokine levels. The effects of inflammation on micronutrient concentrations were partly controlled by including CRP in all the models. There were no significant differences in the Table 3 . Associations between micronutrient status and serum innate chemokine and cytokine levels (n 280) * P,0·05. † OR represents the odds that chemokine or cytokine levels (categorised into three levels: non-detectable, ,median, .median)
will be greater among women with greater serum micronutrient concentrations. ‡ Micronutrient concentrations were included in the model along with C-reactive protein concentrations and age of women. § As in model I and further adjusted for BMI.
associations between models that included CPR compared to models that did not include this inflammatory marker, suggesting that micronutrient concentrations could be affecting inflammatory cytokine levels. Associations were found between specific micronutrient serum concentrations and the odds of having higher concentration of inflammatory markers. The findings in the present study suggest that micronutrients play a different role in low-grade chronic inflammation among individuals with differing degrees of adiposity and obesity. Overall, it was found that higher Zn concentration is associated with reduced risks of higher concentration of inflammation markers. These results are preliminary and so must be interpreted with caution. It is important to continue addressing the relationship between these micronutrients and the inflammatory response especially among populations that differ in the prevalence of overweight and obesity. Such efforts will determine whether such relationships change with changing adiposity, and so establish how specific nutrients may be interacting with adipose tissue to regulate the production of inflammatory cytokines and so modify low-grade inflammation occurring in obesity.
